1.90
Finanzdaten der Alaunos Therapeutics Inc-Aktie (TCRT)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
Revenues |
100.00%
-
|
0.002 | 0.004 | - | 0.004 |
|
5.03%
1.039
|
1.094 | 0.759 | 1.15 | 1.17 |
Benefits Costs and Expenses |
-
|
- | - | - | - |
Costs And Expenses |
4.94%
1.04
|
1.094 | 0.759 | 1.15 | 1.17 |
Operating Income/Loss |
4.85%
-1.039
|
-1.092 | -0.755 | -1.15 | -1.166 |
Nonoperating Income/Loss |
163.16%
-0.012
|
0.019 | 0.013 | 0.023 | 0.037 |
Income/Loss From Continuing Operations Before Tax |
52,650%
-1.051
|
0.002 | 0.004 | -1.127 | 0.004 |
Income/Loss From Continuing Operations After Tax |
2.05%
-1.051
|
-1.073 | -0.742 | -1.127 | -1.129 |
|
2.05%
-1.051
|
-1.073 | -0.742 | -1.127 | -1.129 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
4.69%
1.6763
|
1.6013 | - | 1.6013 | 1.6013 |
Diluted Average Shares |
4.69%
1.6763
|
1.6013 | - | 1.6013 | 1.6013 |
Basic Earnings Per Share |
5.97%
-0.63
|
-0.67 | -0.46 | -0.70 | -0.71 |
Diluted Earnings Per Share |
5.97%
-0.63
|
-0.67 | -0.46 | -0.70 | -0.71 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):